Estimates Revisions 10x Genomics, Inc. Deutsche Boerse AG
Stocks
1KJ
US88025U1097
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
13:01:14 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 77.87 EUR | +5.39% |
|
+18.72% | +476.39% |
| 09-24 | 10x Genomics Insider Sold Shares Worth $464,668, According to a Recent SEC Filing | MT |
| 09-21 | Deutsche Bank Adjusts 10x Genomics Price Target to $70 From $40, Maintains Hold Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
10x Genomics, Inc.(TXG)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
10x Genomics, Inc.(TXG)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
10x Genomics, Inc.(TXG)
EBIT
Dividend / Share (DPS)
Data source:
10x Genomics, Inc.(TXG)
Cash or Net Debt
- Stock Market
- Stocks
- TXG Stock
- 1KJ Stock
- Consensus 10x Genomics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
